This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Precision Biosciences, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Armin Hekele - Innovator in Gene Editing Technologies
Introduction
Armin Hekele is an accomplished inventor based in Cary, NC (US). He is currently associated with Precision Biosciences, Inc., where he focuses on advancements in gene editing technologies. Although he does not hold any granted patents, his contributions to the field are noteworthy.
Latest Patent Applications
Armin Hekele has filed several significant patent applications. One of his latest applications is titled "Optimized Polynucleotides for Protein Expression." This application describes a method for expressing and delivering a polynucleotide encoding a protein of interest, particularly a nuclease associated with a gene-editing system. The method aims to increase the half-life of the mRNA encoding the engineered nuclease, thereby enhancing the protein level and gene editing efficiency. The application also includes pharmaceutical compositions comprising the polynucleotides and methods for modifying the genome of eukaryotic cells using these polynucleotides.
Another notable application is "Engineered Nucleases That Target Human and Canine Factor VIII Genes as a Treatment for Hemophilia A." This invention encompasses engineered nucleases that recognize and cleave a specific sequence within the int22h-1 sequence of a Factor VIII gene. The application outlines methods for using these engineered nucleases to create genetically modified cells, which can be utilized in pharmaceutical compositions and methods for treating hemophilia A.
Conclusion
Armin Hekele's work at Precision Biosciences, Inc. highlights his commitment to advancing gene editing technologies. His latest patent applications reflect innovative approaches to addressing significant medical challenges, particularly in the treatment of genetic disorders.